# Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies

> **NCT01555346** · — · COMPLETED · sponsor: **Sequenom, Inc.** · enrollment: 3062 (actual)

## Conditions studied

- Down Syndrome
- Fetal Aneuploidy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01555346
- **Lead sponsor:** Sequenom, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2014-10
- **Final completion:** 2015-12
- **Target enrollment:** 3062 (ACTUAL)
- **Last updated:** 2016-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01555346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01555346, "Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01555346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*